HIV Drugs: Trigger of Autoimmunity

Implicit, severe immune sensitive reactions to the anti-HIV drug abacavir materialize through an autoimmune procedure, resulting from the design of drug-induced immunizing agent that are attacked by the body's immune system as all HIV Drugs blocks protein synthesis and enzymes which cause alteration in and enzyme synthesis, autoimmune deformities accrue in HIV Patient and proteins. Many times foreign myalgia’s and arthralgia’s occur in about 5% of patients with HIV, sometimes in association with HIV seroconversion.  Many bone related diseases and HIV-associated arthralgia started progresses towards inflammatory joint disease and disorders because of HIV Treatment.

    Related Conference of HIV Drugs: Trigger of Autoimmunity

    March 04-05, 2019

    10th Molecular Immunology & Immunogenetics Congress

    Barcelona, Spain
    March 18-19, 2019

    11th Global Summit on Immunology and Cell Biology

    Sydney, Australia
    March 18-19, 2019

    13th International Congress on Autoimmunity

    Brisbane, Australia
    June 13-14, 2019 |

    10th European Immunology Conference

    Berlin, Germany
    July 24-25, 2019

    11th World Congress and Expo on Immunology

    Vancouver, Canada
    July 29-30 2019

    6th International Conference on Parasitology & Microbiology

    Amsterdam, Netherlands
    October 21-22, 2019

    12th Annual Congress on Immunology & Immunogenetics

    Rome, Italy
    November 22-23, 2019 |

    World Conference on Vaccine and Immunology

    Dubai, UAE

    HIV Drugs: Trigger of Autoimmunity Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in